“Long-term Efficacy and Safety of Brodalumab in Patients With or Without History of Psoriatic Arthritis: Analysis of Two Phase 3 Psoriasis Studies” (2019) SKIN The Journal of Cutaneous Medicine, 3, p. S21. doi:10.25251/skin.3.supp.21.